A-674563 (hydrochloride)
A-674563 hydrochloride is a potent and selective Akt1 inhibitor with Ki of 11 nM.
Product Specifications
CAS Number
[2070009-66-2]
UNSPSC
12352005
Target
Akt
Type
Reference compound
Related Pathways
PI3K/Akt/mTOR
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/A-674563-hydrochloride.html
Purity
99.86
Solubility
DMSO : 50 mg/mL (ultrasonic) |H2O : 100 mg/mL (ultrasonic)
Smiles
N[C@@H](CC1=CC=CC=C1)COC2=CC(C3=CC4=C(C=C3)NN=C4C)=CN=C2.[H]Cl
Molecular Formula
C22H23ClN4O
Molecular Weight
394.90
References & Citations
[1]Luo Y, et al. Potent and selective inhibitors of Akt kinases slow the progress of tumors in vivo. Mol Cancer Ther, 2005, 4 (6), 977-986.|[2]Zhu QS, et al. Soft tissue sarcoma cells are highly sensitive to AKT blockade: a role for p53-independent up-regulation of GADD45 alpha. Cancer Res, 2008, 68 (8), 2895-2903.|[3]Zou Y, et al. Pre-clinical assessment of A-674563 as an anti-melanoma agent. Biochem Biophys Res Commun. 2016 Aug 12;477 (1) :1-8.|[4]Xu L, et al. Concurrent targeting Akt and sphingosine kinase 1 by A-674563 in acute myeloid leukemia cells. Biochem Biophys Res Commun. 2016 Apr 15;472 (4) :662-8.
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, stored under nitrogen, away from moisture)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
Akt1
Citation 01
Aging. 2020 Nov 17;12 (22) :23114-23128.|Cell Commun Signal. 2025 Apr 23;23 (1) :194.|Cell Signal. 2023 Sep:109:110753.|J Proteome Res. 2018 Oct 5;17 (10) :3360-3369.|Oncotarget. 2016 May 17;7 (20) :29131-42.
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
333247-01 50 µg
RUNX3 (Acute Myeloid Leukemia 2 Protein, Acute Myeloid Leukemia Gene 2, AML 2, AML2, CBF alpha 3, CBF-alpha-3, CBFA 3, CBFA3, Core Binding Factor alpha 3 Subunit, Core Binding Factor, Core Binding Factor Runt Domain alpha Subunit 3, Core Binding Factor Subunit alpha 3, Core-binding Factor, Core-binding Factor Subunit alpha-3, Oncogene AML 2, Oncogene AML-2, PEA2 alpha C, PEA2-alpha C, PEBP2 alpha C, PEBP2-alpha C, Pebp2a3, PEBP2aC, Polyomavirus Enhancer Binding Protein 2 alpha C Subunit, Polyomavirus Enhancer-binding Protein 2 alpha C Subunit, Runt Domain alpha Subunit 3, Runt Related Transcription Factor 3, Runt-related Transcription Factor 3, RUNX 3, Runx3, SL3 3 Enhancer Factor 1 alpha C Subunit, SL3-3 Enhancer Factor 1 alpha C Subunit, SL3/AKV Core Binding Factor alpha C Subunit, SL3/AKV Core-binding Factor alpha C Subunit, Transcription Factor AML2)
Ask
View Details 333247-02 100 µg
RUNX3 (Acute Myeloid Leukemia 2 Protein, Acute Myeloid Leukemia Gene 2, AML 2, AML2, CBF alpha 3, CBF-alpha-3, CBFA 3, CBFA3, Core Binding Factor alpha 3 Subunit, Core Binding Factor, Core Binding Factor Runt Domain alpha Subunit 3, Core Binding Factor Subunit alpha 3, Core-binding Factor, Core-binding Factor Subunit alpha-3, Oncogene AML 2, Oncogene AML-2, PEA2 alpha C, PEA2-alpha C, PEBP2 alpha C, PEBP2-alpha C, Pebp2a3, PEBP2aC, Polyomavirus Enhancer Binding Protein 2 alpha C Subunit, Polyomavirus Enhancer-binding Protein 2 alpha C Subunit, Runt Domain alpha Subunit 3, Runt Related Transcription Factor 3, Runt-related Transcription Factor 3, RUNX 3, Runx3, SL3 3 Enhancer Factor 1 alpha C Subunit, SL3-3 Enhancer Factor 1 alpha C Subunit, SL3/AKV Core Binding Factor alpha C Subunit, SL3/AKV Core-binding Factor alpha C Subunit, Transcription Factor AML2)
Ask
View Details